• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

How chronic inflammation may drive down dopamine and motivation

Bioengineer by Bioengineer
June 4, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A computational method to experimentally test a theory

Growing evidence shows that the brain’s dopamine system, which drives motivation, is directly affected by chronic, low-grade inflammation. A new paper proposes that this connection between dopamine, effort and the inflammatory response is an adaptive mechanism to help the body conserve energy.

Trends in Cognitive Sciences published the theoretical framework developed by scientists at Emory University. The authors also provided a computational method to experimentally test their theory.

“When your body is fighting an infection or healing a wound, your brain needs a mechanism to recalibrate your motivation to do other things so you don’t use up too much of your energy,” says corresponding author Michael Treadway, an associate professor in Emory’s Department of Psychology, who studies the relationship between motivation and mental illness. “We now have strong evidence suggesting that the immune system disrupts the dopamine system to help the brain perform this recalibration.”

The computational method will allow scientists to measure the effects of chronic inflammation on energy availability and effort-based decision-making. The method may yield insights into how chronic, low-grade inflammation contributes to motivational impairments in some cases of depression, schizophrenia and other medical disorders.

Co-author Andrew Miller, William P. Timmie Professor of Psychiatry and Behavioral Sciences in Emory’s School of Medicine and the Winship Cancer Institute, is a leader in this field and is pioneering the development of immunotherapeutic strategies for the treatment of psychiatric disorders.

“If our theory is correct, then it could have a tremendous impact on treating cases of depression and other behavioral disorders that may be driven by inflammation,” Miller says. “It would open up opportunities for the development of therapies that target energy utilization by immune cells, which would be something completely new in our field.”

Co-author Jessica Cooper, a post-doctoral fellow in Treadway’s lab, led the development of the computational model.

It has previously been shown that inflammatory cytokines — signaling molecules used by the immune system — impact the mesolimbic dopamine system. And recent research has revealed more insights into how immune cells can shift their metabolic states differently from most other cells.

The researchers built on these findings to develop their theoretical framework.

An immune-system mechanism to help regulate the use of energy resources during times of acute stress was likely adaptive in our ancestral environments, rife with pathogens and predators. In modern environments, however, many people are less physically active and may have low-grade inflammation due to factors such as chronic stress, obesity, metabolic syndrome, aging and other factors. Under these conditions, the same mechanism to conserve energy for the immune system could become maladaptive, the authors theorize.

Studies by Miller and others have provided evidence of an association between an elevated immune system, reduced levels of dopamine and motivation, and some diagnoses of depression, schizophrenia and other mental disorders.

“We’re not proposing that inflammation causes these disorders,” Treadway says. “The idea is that a subset of people with these disorders may have a particular sensitivity to the effects of the immune system and this sensitivity could contribute to the motivational impairments they are experiencing.”

The researchers are now using their computational method to test their theory in a clinical trial on depression.

###

The work for the current paper was supported by the National Institute of Mental Health.

Media Contact
Carol Clark
[email protected]
http://dx.doi.org/10.1016/j.tics.2019.03.003

Tags: Algorithms/ModelsBehaviorImmunology/Allergies/AsthmaMedicine/HealthMental HealthMetabolism/Metabolic Diseasesneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

BU Researchers Receive $2.1 Million Grant to Advance Training in Biomolecular Pharmacology

BU Researchers Receive $2.1 Million Grant to Advance Training in Biomolecular Pharmacology

August 12, 2025
blank

Combo Therapy Outperforms SGLT2 Alone in MASLD

August 12, 2025

Remote Real-Time Monitoring Revolutionizes Parkinson’s Care

August 12, 2025

Exercise May Decelerate Epigenetic Aging, New Study Finds

August 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    78 shares
    Share 31 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cancer Cells Evade Anti-Cancer Drugs by Hiding and Thriving Within Bone Marrow Fibroblasts

Revolutionary Research Unveils “Pore Science and Engineering” Paving the Way for Next-Generation Porous Materials

KAIST Unveils Revolutionary Wireless OLED Contact Lens for Retinal Diagnostics

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.